Cargando…
Biomarkers in renal cell carcinoma: Towards a more selective immune checkpoint inhibition
Immune checkpoint inhibitors such as programmed death protein 1/programmed death-ligand 1 and cytotoxic T-lymphocyte–associated protein 4 inhibitors are already playing a central role in the treatment of metastatic renal cell carcinoma. However, they seem to be only effective in a subset of patients...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985395/ https://www.ncbi.nlm.nih.gov/pubmed/33744727 http://dx.doi.org/10.1016/j.tranon.2021.101071 |